Biotin and hair: what the science really says

Few hair-care aisles are missing biotin: ampoules, capsules, serums, the words biotin hair appear on almost every box, with promises that exceed the Swiss regulatory frame. This omnipresence blurs the reading of a vitamin whose metabolic role is precisely documented. The consumer's question is about growth, when it should be about enzymatic function and the conditions that make an intake useful. The answer holds in three elements: what the law allows and what biochemistry establishes, biotin's place among the other nutrients of the follicle, and a documented analytical interference that labels keep silent.

What biotin actually does

The claim authorised in Switzerland reads: biotin contributes to the maintenance of normal hair and normal skin. Every word carries weight. Contribute places biotin among several factors of a multi-factor process. Maintenance designates the upkeep of an existing structure. Normal refers to expected physiological function in a person whose intakes cover needs. The legal frame recognises a maintenance role for the capillary framework, and stops at that frontier.

This wording matches exactly what biochemistry establishes. Biotin, called vitamin B8 in the European and French tradition and B7 in Anglo-Saxon usage, is a water-soluble vitamin at the crossroads of tissue construction and energy production. It serves as coenzyme of five human carboxylases (Zempleni 2008): acetyl-CoA carboxylase starts fatty-acid synthesis, including the ceramides of the scalp; pyruvate carboxylase opens gluconeogenesis; propionyl-CoA and methylcrotonyl-CoA carboxylases break down certain amino acids, notably branched-chain ones. Biotin thus takes part simultaneously in storing energy, producing it, and recycling proteins.

On these reactions depends the making of keratin, the structural protein of hair, skin and nails. By supporting this protein framework, biotin contributes to nail solidity, hair-fibre vitality and skin-barrier integrity. It also participates in melanin synthesis, the pigment of skin and hair. A share of needs comes from the gut microbiota, which makes biotin in the colon: this endogenous production explains why deficiency is rare with a balanced flora, and why it appears with installed dysbiosis, repeated antibiotics, long-term anticonvulsants or regular raw egg-white consumption, whose avidin binds biotin and blocks its absorption. The deficiency picture combines fatigue, hair loss, brittle nails, eczema-like dermatoses and loss of muscle reflexes.

Hair loss and deficiencies: biotin, zinc, selenium, iron

The query "female hair loss" reflects a frequent reality whose micronutritional origin deserves exploration before anything else. Four nutrients act on this route by distinct mechanisms, and reading them together gives the real picture. Biotin supports the keratin framework through the carboxylases above; it contributes to the maintenance of normal hair and skin. Zinc acts in follicle cell division and protein synthesis; base One provides 5 mg as citrate; it contributes to the maintenance of normal hair, nails and skin. Selenium enters the selenoproteins and thyroid deiodinases whose activity commands the hair cycle; base One provides 55 µg as L-selenomethionine; it contributes to the maintenance of normal hair and nails. Iron conditions follicle oxygenation; its status reads on ferritin, among the first parameters to request in diffuse hair loss. It stays out of base One because of its competition with zinc at the DMT1 transporter, and vitamin C at 580 mg supports the absorption of dietary non-heme iron indirectly.

The hair-vitamin aisle rests on a repetitive architecture: a headline biotin dose, a few minerals in symbolic amounts, decorative plant extracts. Three checks sort a hair supplement: the real quantity of each nutrient per daily dose against the reference value; the chemical form, a zinc citrate and a zinc oxide appearing under the same name on the front; and the coherence of the whole, because an isolated biotin acts on one link of a chain that counts several. Exploration through blood work remains the relevant approach, with a practitioner trained to read these parameters.

The precaution nobody mentions: biotin distorts certain blood tests

Here is the point of honesty that any supplemented person deserves to know. Many blood assays rest on the biotin-streptavidin pair, whose affinity counts among the strongest in biology. Excess circulating biotin saturates the reagent's streptavidin sites and skews the result, in a direction that depends on the assay format: competitive assays return falsely high values, sandwich assays falsely low ones (Piketty 2017).

The FDA published a safety communication on this subject in November 2017, updated in 2019, after a death linked to a falsely lowered troponin in a biotin-supplemented patient. The affected assays include cardiac troponin, the whole thyroid panel (TSH, free T4, free T3, anti-TPO antibodies), several hormone assays and some tumour markers. A falsely low TSH with a falsely high free T4 reproduces exactly the biological profile of hyperthyroidism, with the risk of erroneous conclusion that follows. The right conduct holds in two simple gestures: suspend supplementation a few days before the blood draw, and tell the laboratory about the biotin intake.

It becomes imperative at high intakes. Orthomolecular medicine uses doses up to 5,000 µg per day to accompany situations of intense tissue renewal, notably during chemotherapy treatments that frequently cause hair loss, aiming to support keratin production and tissue repair. Over prolonged intakes, from months to more than a year, no toxicity has been reported in the field; these reports belong to clinical observation. Indexed literature provides a safety-margin landmark: Sedel et al. (2015) administered 300 mg of biotin daily to patients with progressive multiple sclerosis over a prolonged period, with a favourable tolerance profile.

800 µg in base One: why this dose

base One provides 800 µg of biotin per 6 g dose, or 1,600% of the reference value of 50 µg. This dose corresponds to the orthomolecular preventive range of 500 to 800 µg per day. Three reasons found it. Microbiota dependence justifies an exogenous intake that compensates the variability of endogenous production, which drops precisely in people whose flora has been altered. Tissue demand runs continuously: skin, hair and nails renew without interruption, consuming enzymatic cofactors that everyday food covers unevenly. Formula coherence completes the whole: biotin collaborates with vitamins B2, B3, B6 and B9 in the cross-activation of B-group cofactors; it works with zinc and vitamin C in keratin and melanin synthesis; glycine at 750 mg supplies the substrate of the dermal collagen matrix in which the follicle anchors. The safety margin is wide: biotin is water-soluble, its excess leaves in urine, and EFSA has set no upper safety limit for lack of documented adverse effect (EFSA 2006).

FAQ

How long before an effect on hair?

The hair cycle imposes its rhythm: the anagen growth phase lasts years, the telogen rest phase about three months. A change in micronutritional status shows on the visible fibre with this minimal delay of three months, which corresponds exactly to a 90-day course.

Biotin or vitamin B8?

Both terms designate the same molecule. B8 prevails in French usage, B7 in Anglo-Saxon usage.

Should you stop biotin before a blood test?

Yes. Suspending a few days before the draw, and informing the laboratory, removes any interference risk on immunoassays, particularly the thyroid panel and troponin.

David Giovenco · Micronutrition researcher · President, Académie Internationale Francophone de Médecine Orthomoléculaire et Intégrative · Founder & Formulator, nuho

Sources

Zempleni 2008 · Sedel 2015 · Mock 2016 · Piketty 2017 · FDA Safety Communication 2017 (update 2019) · EFSA 2006 · Almohanna 2019.